The protein biomarker-based test will be used to identify patients at high risk of cancer in order to prioritize them for conventional cancer screening methods.

UHealth, University of Miami Miller School of Medicine joined Aclarion’s trial of the Nociscan diagnostic spine tool, according to a June 10 news release. The Clarity trial is a prospective, ...

Four days after Governor Greg Abbott signed House Bill 2 into law, allocating billions in public education funding and ...

Single-use medical devices gain traction globally as hospitals prioritize hygiene, safety, and efficiency in patient care. With demand rising, the single-use medical devices market will jump from ...

Hernias affect millions of people every year, yet many patients and even some medical professionals remain unaware of how the ...

Siddarth Nandyala wanted to provide a non-invasive, affordable tool for early detection of cardiovascular issues.

A team at the University of California, Los Angeles has developed a low-cost diagnostic pen that converts handwriting into ...

Advancements in Genomics and AI Propel Patient-Centric Therapies Across Key Regions The global personalized medicine market ...

Two Central Texas high school students are developing an app that detects if generative AI was used to complete handwritten ...

The smartphone-sized, battery-powered test is a cost-effective tool that can improve TB diagnoses, particularly in rural ...